intraneuronal toxin metalloprotease inhibitors (PanThera)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameintraneuronal toxin metalloprotease inhibitors (PanThera)
Drug Alias Namesmall molecule antitoxins (PanThera Biopharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBotulinum toxin inhibitorsMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinaseBotulinum toxin
Therapy Area/IndicationsBotulism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPanThera Biopharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPanThera Biopharma LLC
Active IndicationsN/A
Inactive IndicationsBotulism

Other Information

ATC CodeN/A
Related LinksN/A